Compass Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Compass Therapeutics, Inc. has filed 352 SEC EDGAR filings since 30 May 2018

SEC filing history

Showing 126-150 of 352 matching filings.

Per page
25
Current page
6
4

4 filing

Filing date
11 Mar 2024
Reporting date
08 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Feb 2024
Reporting date
09 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Feb 2024
Reporting date
09 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Feb 2024
Reporting date
09 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Feb 2024
Reporting date
09 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Feb 2024
Reporting date
09 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90878

SC 13G/A filing

Filing date
09 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90878

COMPASS THERAPEUTICS, INC.

Filing date
07 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90878

JANUS HENDERSON GROUP PLC OWNS 6.00% OF COMPASS THERAPEUTICS, INC.

Filing date
01 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Jan 2024
Reporting date
09 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Jan 2024
Reporting date
09 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90878

COMPASS THERAPEUTICS, INC.

Filing date
27 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Nov 2023
Reporting date
17 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Nov 2023
Reporting date
17 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .